Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao-Wen Zhang
Xin-Lin Zhang
Biao Xu
Li-Na Kang
机构：
[1] Nanjing University School of Medicine,Department of Endocrinology, Affiliated Drum Tower Hospital
[2] Nanjing University School of Medicine,Department of Cardiology, Affiliated Drum Tower Hospital
来源：
Acta Diabetologica | 2018年 / 55卷
关键词：
Insulin degludec; Insulin glargine; Hypoglycemia; Meta-analysis; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 441
页数：12
相关论文
共 50 条
  • [11] Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
    Sylvie Erpeldinger
    Michaela B. Rehman
    Christophe Berkhout
    Christophe Pigache
    Yves Zerbib
    Francis Regnault
    Emilie Guérin
    Irène Supper
    Catherine Cornu
    Behrouz Kassaï
    François Gueyffier
    Rémy Boussageon
    BMC Endocrine Disorders, 16
  • [12] Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
    Erpeldinger, Sylvie
    Rehman, Michaela B.
    Berkhout, Christophe
    Pigache, Christophe
    Zerbib, Yves
    Regnault, Francis
    Guerin, Emilie
    Supper, Irene
    Cornu, Catherine
    Kassai, Behrouz
    Gueyffier, Francois
    Boussageon, Remy
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [13] Efficacy and Safety of Basal Insulin Fc versus Degludec Insulin: A Meta-Analysis of Randomized Controlled Trials
    Ayesh, Hazem
    Ayesh, Suhail
    Niswender, Kevin
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (05) : e588 - e591
  • [14] A Randomized Crossover Study of the Efficacy and Safety of Switching from Insulin Glargine to Insulin Degludec in Children with Type 1 Diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    DIABETES, 2015, 64 : A366 - A366
  • [15] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2017, 64 (02) : 133 - 140
  • [16] Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
    Edina, Brenda C.
    Tandaju, Jeremy R.
    Wiyono, Lowilius
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [17] Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
    Ratner, R. E.
    Gough, S. C. L.
    Mathieu, C.
    Del Prato, S.
    Bode, B.
    Mersebach, H.
    Endahl, L.
    Zinman, B.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02): : 175 - 184
  • [18] Efficacy and safety of switching from insulin glargine to insulin degludec in young people with type 1 diabetes
    Urakami, Tatsuhiko
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2016, 63 (02) : 159 - 167
  • [19] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
  • [20] Hypoglycemia and glycemic control in type 1 diabetes: a meta-analysis of five randomized controlled trials comparing NPH insulin with insulin glargine
    Mullins, Peter
    Jarvinen, Hannele Yki
    Sharplin, Peter A.
    Riddle, Matthew
    DIABETES, 2007, 56 : A575 - A576
12345